Details for New Drug Application (NDA): 202688
✉ Email this page to a colleague
The generic ingredient in PROPAFENONE HYDROCHLORIDE is propafenone hydrochloride. There are eleven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the propafenone hydrochloride profile page.
Summary for 202688
Tradename: | PROPAFENONE HYDROCHLORIDE |
Applicant: | Watson Labs Inc |
Ingredient: | propafenone hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 202688
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PROPAFENONE HYDROCHLORIDE | propafenone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 202688 | ANDA | Actavis Pharma, Inc. | 0591-2285 | 0591-2285-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-2285-60) |
PROPAFENONE HYDROCHLORIDE | propafenone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 202688 | ANDA | Actavis Pharma, Inc. | 0591-2286 | 0591-2286-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-2286-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 225MG | ||||
Approval Date: | Aug 24, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 325MG | ||||
Approval Date: | Aug 24, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 425MG | ||||
Approval Date: | Aug 24, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription